Completed OBSERVATIONAL NCT02827448

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

Sponsor: Baylor Research Institute

Conditions Acute Kidney Injury Heart Failure

Updated 8 times since 2017 Last updated: Jul 9, 2019 Started: Nov 30, 2015 Primary completion: Aug 31, 2017 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02827448, this observational or N/A phase trial focuses on Acute Kidney Injury and Heart Failure and remains completed. Sponsored by Baylor Research Institute, it has been updated 8 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2019 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Jun 2018 — Aug 2019 [monthly]

Recruiting

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor Research Institute

Data source: Baylor Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States